Biomarkers of left ventricular hypertrophy and remodeling in blacks

Thais Coutinho, Malik Al-Omari, Thomas H. Mosley, Iftikhar Jan Kullo

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Left ventricular (LV) hypertrophy, a marker for adverse cardiovascular events, is more common in blacks than in non-Hispanic whites. Mechanisms leading to LV hypertrophy and mediating its clinical sequelae in blacks are not fully understood. We investigated the associations of 39 candidate biomarkers in distinct biological pathways with LV mass and geometry in blacks. Participants included 1193 blacks (63±9 years of age; 72% women; 78% hypertensive) belonging to hypertensive sibships. LV mass was measured by transthoracic echocardiography and indexed to height. 2.7LV geometry was categorized as normal, concentric remodeling, concentric hypertrophy, and eccentric hypertrophy. Generalized estimating equations were used to assess associations of the 39 biomarkers with LV mass index after adjustment for age, sex, and conventional risk factors. After adjustment for potential confounders, log-transformed levels of the following biomarkers were independently associated with LV mass index: N-terminal pro-brain natriuretic peptide (β±SE=0.07±0.01 pg/mL; P<0.0001), mid-regional pro-atrial natriuretic peptide (β±SE=0.08±0.02 pmol/L; P<0.0001), mid-regional pro-adrenomedullin (β±SE=0.09±0.03 nmol/L; P=0.0006), C-terminal pro-endothelin (β± SE=0.05±0.02 pmol/L; P=0.0009), and osteoprotegerin (β±SE=0.07±0.02 pg/mL; P=0.0005) (β is for 1 log increase in biomarker level). The associations of these biomarkers with LV mass index were mainly due to their association with eccentric hypertrophy. Higher circulating levels of natriuretic peptides, adrenomedullin, endothelin, and osteoprotegerin were associated with increased LV mass index, providing insights into the pathophysiology of LV hypertrophy in blacks.

Original languageEnglish (US)
Pages (from-to)920-925
Number of pages6
JournalHypertension
Volume58
Issue number5
DOIs
StatePublished - Nov 2011

Fingerprint

Ventricular Remodeling
Left Ventricular Hypertrophy
Biomarkers
Hypertrophy
Adrenomedullin
Osteoprotegerin
Endothelins
Natriuretic Peptides
Brain Natriuretic Peptide
Atrial Natriuretic Factor
Echocardiography

Keywords

  • Adrenomedullin
  • Atrial natriuretic peptide
  • Biomarkers
  • Brain natriuretic peptide
  • Endothelin
  • Left ventricular hypertrophy
  • Osteoprotegerin

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Biomarkers of left ventricular hypertrophy and remodeling in blacks. / Coutinho, Thais; Al-Omari, Malik; Mosley, Thomas H.; Kullo, Iftikhar Jan.

In: Hypertension, Vol. 58, No. 5, 11.2011, p. 920-925.

Research output: Contribution to journalArticle

Coutinho, Thais ; Al-Omari, Malik ; Mosley, Thomas H. ; Kullo, Iftikhar Jan. / Biomarkers of left ventricular hypertrophy and remodeling in blacks. In: Hypertension. 2011 ; Vol. 58, No. 5. pp. 920-925.
@article{6da2058290904e1880c8f96c7ba4b6f2,
title = "Biomarkers of left ventricular hypertrophy and remodeling in blacks",
abstract = "Left ventricular (LV) hypertrophy, a marker for adverse cardiovascular events, is more common in blacks than in non-Hispanic whites. Mechanisms leading to LV hypertrophy and mediating its clinical sequelae in blacks are not fully understood. We investigated the associations of 39 candidate biomarkers in distinct biological pathways with LV mass and geometry in blacks. Participants included 1193 blacks (63±9 years of age; 72{\%} women; 78{\%} hypertensive) belonging to hypertensive sibships. LV mass was measured by transthoracic echocardiography and indexed to height. 2.7LV geometry was categorized as normal, concentric remodeling, concentric hypertrophy, and eccentric hypertrophy. Generalized estimating equations were used to assess associations of the 39 biomarkers with LV mass index after adjustment for age, sex, and conventional risk factors. After adjustment for potential confounders, log-transformed levels of the following biomarkers were independently associated with LV mass index: N-terminal pro-brain natriuretic peptide (β±SE=0.07±0.01 pg/mL; P<0.0001), mid-regional pro-atrial natriuretic peptide (β±SE=0.08±0.02 pmol/L; P<0.0001), mid-regional pro-adrenomedullin (β±SE=0.09±0.03 nmol/L; P=0.0006), C-terminal pro-endothelin (β± SE=0.05±0.02 pmol/L; P=0.0009), and osteoprotegerin (β±SE=0.07±0.02 pg/mL; P=0.0005) (β is for 1 log increase in biomarker level). The associations of these biomarkers with LV mass index were mainly due to their association with eccentric hypertrophy. Higher circulating levels of natriuretic peptides, adrenomedullin, endothelin, and osteoprotegerin were associated with increased LV mass index, providing insights into the pathophysiology of LV hypertrophy in blacks.",
keywords = "Adrenomedullin, Atrial natriuretic peptide, Biomarkers, Brain natriuretic peptide, Endothelin, Left ventricular hypertrophy, Osteoprotegerin",
author = "Thais Coutinho and Malik Al-Omari and Mosley, {Thomas H.} and Kullo, {Iftikhar Jan}",
year = "2011",
month = "11",
doi = "10.1161/HYPERTENSIONAHA.111.178095",
language = "English (US)",
volume = "58",
pages = "920--925",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Biomarkers of left ventricular hypertrophy and remodeling in blacks

AU - Coutinho, Thais

AU - Al-Omari, Malik

AU - Mosley, Thomas H.

AU - Kullo, Iftikhar Jan

PY - 2011/11

Y1 - 2011/11

N2 - Left ventricular (LV) hypertrophy, a marker for adverse cardiovascular events, is more common in blacks than in non-Hispanic whites. Mechanisms leading to LV hypertrophy and mediating its clinical sequelae in blacks are not fully understood. We investigated the associations of 39 candidate biomarkers in distinct biological pathways with LV mass and geometry in blacks. Participants included 1193 blacks (63±9 years of age; 72% women; 78% hypertensive) belonging to hypertensive sibships. LV mass was measured by transthoracic echocardiography and indexed to height. 2.7LV geometry was categorized as normal, concentric remodeling, concentric hypertrophy, and eccentric hypertrophy. Generalized estimating equations were used to assess associations of the 39 biomarkers with LV mass index after adjustment for age, sex, and conventional risk factors. After adjustment for potential confounders, log-transformed levels of the following biomarkers were independently associated with LV mass index: N-terminal pro-brain natriuretic peptide (β±SE=0.07±0.01 pg/mL; P<0.0001), mid-regional pro-atrial natriuretic peptide (β±SE=0.08±0.02 pmol/L; P<0.0001), mid-regional pro-adrenomedullin (β±SE=0.09±0.03 nmol/L; P=0.0006), C-terminal pro-endothelin (β± SE=0.05±0.02 pmol/L; P=0.0009), and osteoprotegerin (β±SE=0.07±0.02 pg/mL; P=0.0005) (β is for 1 log increase in biomarker level). The associations of these biomarkers with LV mass index were mainly due to their association with eccentric hypertrophy. Higher circulating levels of natriuretic peptides, adrenomedullin, endothelin, and osteoprotegerin were associated with increased LV mass index, providing insights into the pathophysiology of LV hypertrophy in blacks.

AB - Left ventricular (LV) hypertrophy, a marker for adverse cardiovascular events, is more common in blacks than in non-Hispanic whites. Mechanisms leading to LV hypertrophy and mediating its clinical sequelae in blacks are not fully understood. We investigated the associations of 39 candidate biomarkers in distinct biological pathways with LV mass and geometry in blacks. Participants included 1193 blacks (63±9 years of age; 72% women; 78% hypertensive) belonging to hypertensive sibships. LV mass was measured by transthoracic echocardiography and indexed to height. 2.7LV geometry was categorized as normal, concentric remodeling, concentric hypertrophy, and eccentric hypertrophy. Generalized estimating equations were used to assess associations of the 39 biomarkers with LV mass index after adjustment for age, sex, and conventional risk factors. After adjustment for potential confounders, log-transformed levels of the following biomarkers were independently associated with LV mass index: N-terminal pro-brain natriuretic peptide (β±SE=0.07±0.01 pg/mL; P<0.0001), mid-regional pro-atrial natriuretic peptide (β±SE=0.08±0.02 pmol/L; P<0.0001), mid-regional pro-adrenomedullin (β±SE=0.09±0.03 nmol/L; P=0.0006), C-terminal pro-endothelin (β± SE=0.05±0.02 pmol/L; P=0.0009), and osteoprotegerin (β±SE=0.07±0.02 pg/mL; P=0.0005) (β is for 1 log increase in biomarker level). The associations of these biomarkers with LV mass index were mainly due to their association with eccentric hypertrophy. Higher circulating levels of natriuretic peptides, adrenomedullin, endothelin, and osteoprotegerin were associated with increased LV mass index, providing insights into the pathophysiology of LV hypertrophy in blacks.

KW - Adrenomedullin

KW - Atrial natriuretic peptide

KW - Biomarkers

KW - Brain natriuretic peptide

KW - Endothelin

KW - Left ventricular hypertrophy

KW - Osteoprotegerin

UR - http://www.scopus.com/inward/record.url?scp=83155181505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83155181505&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.111.178095

DO - 10.1161/HYPERTENSIONAHA.111.178095

M3 - Article

C2 - 21986506

AN - SCOPUS:83155181505

VL - 58

SP - 920

EP - 925

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 5

ER -